GOV.UK
Actions we're taking to prevent drug-related deaths
The ONS has published the latest figures for drug-related deaths in England and Wales, covering all deaths registered in 2016.
Rosanna O’Connor
Rosanna O’Connor is Director, Alcohol, Drugs & Tobacco within the Health and Wellbeing Directorate of Public Health England (PHE). PHE was established in April 2013 with a mission to protect and improve the nation’s health and to address inequalities. Rosanna was previously Director of Delivery at the National Treatment Agency for Substance Misuse (NTA). Having joined the NTA in 2003, she quickly assumed responsibility for all the agency’s operational activity. Rosanna was a previous Board member of the Youth Justice Board, chairing the Secure Accommodation Committee.
Rosanna previously held senior positions in two national voluntary sector organisations, building a significant track record of developing and delivering community, residential and prison-based services for a range of disadvantaged and complex groups of people.
Rosanna’s interest in health inequalities of individuals and communities is based on extensive experience of local communities, having been a leading elected member for 14 years, rooted in voluntary work primarily aimed at giving a voice to people marginalised by the system.
The importance of hepatitis C treatment for people who inject drugs
Each year on 28 July the World Hepatitis Alliance brings together patient organisations, governments, medical professionals and industry for World Hepatitis Day (WHD).
The Government Drug Strategy - tackling the complex issue of drug misuse
The new Government Drug Strategy sets out how the Government will tackle the complex issue of drug misuse. We have made progress in recent years but challenges remain, including the increasing rates in drug related deaths.
Health Matters - Your questions on preventing drug misuse deaths
We hope our latest edition of Health Matters – on the subject of “Preventing drug misuse deaths– will help you and other health professionals by compiling key facts, figures and evidence of effective interventions.
Reviewing the evidence on drug misuse treatment
We've published an evidence review of the outcomes that can be expected of drug misuse treatment in England, which was commissioned by the Department of Health in 2015 and has helped inform the forthcoming government Drugs Strategy. How England drug …
What we know about young people in alcohol and drug treatment
This week PHE has published two important documents about young people’s substance misuse.
Expert interview: Carrying out our alcohol evidence review
What’s the public health impact of alcohol and what is the effectiveness of policies for reducing alcohol-related harm? PHE’s new evidence review seeks to answer those questions and you’ll find the full document on GOV.UK and an abridged version published …
What we've learned from our annual drug and alcohol treatment statistics
PHE has released its annual drug and alcohol treatment statistics for 2015-16. This report brings together information on adults receiving specialist interventions for both drug and alcohol problems, recognising that many people experience problems with more than one substance – so …
We must escalate efforts to prevent drug-related deaths
Deaths caused by drug misuse are rising. In order to help us take effective action we need to better understand the multiple and complex causes behind this disturbing trend. Last year, Public Health England and the Local Government Association convened …
Tools for assessing value for money for alcohol and drug treatment
In 2014-15 there were 295,244 adults in alcohol and drug treatment services across England. The latest official statistics on drug-related deaths in England showed the highest number of substance misuse related death since these records began and highlights a worrying …